European Pharmaceutical Contract Manufacturing Market Growth, Opportunity, Size, Share and Forecast 2019-2025

European pharmaceutical contract manufacturing market is growing significantly due to cost-effective production, increased inventory and so forth that are otherwise major concerns for the pharmaceutical manufacturers. In addition, rapid turnaround time to introduce new drugs to the market is also a critical concern for pharmaceutical companies. Therefore, contract manufacturing organizations are emerging as an effective alternative to pharmaceutical companies. The partnership with CDMO (contract development & manufacturing organization) enables pharmaceutical firms to reduce drug development cost and save time for further processes.

Request a Free Sample of our Report on European Pharmaceutical Contract Manufacturing Market: https://www.omrglobal.com/request-sample/european-pharmaceutical-contract-manufacturing-market

Moreover, the major factor supporting the growth of European pharmaceutical contract manufacturing market include soaring European pharmaceutical industry. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), production of pharmaceutical products in Europe has reached $257 billion in 2015 which was approximately 16.4% higher than the production in 2010. This represents the growing demand for pharmaceutical products in the region, which in turn is driving the demand for European CDMO to meet the increasing demand for pharmaceutical products and support in R&D activities.

Additionally, significant pharmaceutical R&D spending by European economies, increasing demand for generic drugs and the presence of major players is further contributing towards the market growth. However, issues over quality control and shift towards Asia-Pacific countries such as India and China for pharmaceutical outsourcing are hindering the growth of European pharmaceutical contract manufacturing market. In addition, advances in drug discovery and increasing R&D investment by contract manufacturers are expected to create a significant opportunity for the market in the near future.

A Full Report of European Pharmaceutical Contract Manufacturing Market is Available at https://www.omrglobal.com/industry-reports/european-pharmaceutical-contract-manufacturing-market

European Pharmaceutical Contract Manufacturing Market Segmentation

By Manufacturing Process Type
o Sterile Manufacturing
o Non-Sterile Manufacturing

By Product Type
o Over-The-Counter (OTC) Drugs
o Active Pharmaceutical Ingredients (API)
o Finished Dosage Formulation
o Others (Nutritional Products and Packaging)

By Route of Administration
o Oral Administration
o Inhaled Administration
o Parenteral Administration
o Others (Rectal and Vaginal)

By Service
o R&D
o Manufacturing
o Non-Clinical Service Such as Supply Chain Management

Company Profiles
o Aenova Group GmbH
o Aesica Pharmaceuticals Ltd.
o Almac Group Ltd.
o Aurena Laboratories AB
o B. Braun Medical Inc.
o Beltapharm SPA
o Bio-Synergy Ltd.
o Boehringer Ingelheim International GmbH
o Cenexi SAS
o Corden Pharma International GmbH
o Delorbis Pharmaceuticals Ltd.
o Delpharm SAS
o Esteve Qu�mica SA
o Ever Neuro Pharma GmbH

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-pharmaceutical-contract-manufacturing-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.